Earnings Feed
Start Free
Home/Filings/4/0001214659-17-007030
4//SEC Filing

Bankier Alain D 4

Accession 0001214659-17-007030

CIK 0001625288other
View on SEC.govCompany Profile

Filed

Nov 29, 7:00 PM ET

Accepted

Nov 30, 1:25 PM ET

Size

11.7 KB

Accession

0001214659-17-007030

Insider Transaction Report

Form 4
Period: 2017-11-29
Intiva BioPharma Inc.KDRH
Bankier Alain D
Director
Transactions
  • Other

    Class B Warrants (right to buy)

    2017-11-29+28,000→ 28,000 total
    Exercise: $0.38From: 2017-11-29Exp: 2018-05-07→ Common Stock (28,000 underlying)
  • Other

    Common Stock

    2017-11-29+1,384,083→ 2,200,000 total
  • Other

    Class A Warrants (right to buy)

    2017-11-29+28,000→ 28,000 total
    Exercise: $0.25From: 2017-11-29Exp: 2018-01-31→ Common Stock (28,000 underlying)
  • Other

    Class C Warrants (right to buy)

    2017-11-29+28,000→ 28,000 total
    Exercise: $0.50From: 2017-11-29Exp: 2018-07-14→ Common Stock (28,000 underlying)
Footnotes (5)
  • [F1]As adjusted to reflect a one-for-six reverse split of the issuer's common stock effective November 29, 2017
  • [F2]Acquired in exchange for all of Alain Bankier's shares of Intiva BioPharma Inc.
  • [F3]Acquired in exchange for all of Alain Bankier's Class A warrants of Intiva BioPharma Inc.
  • [F4]Acquired in exchange for all of Alain Bankier's Class B warrants of Intiva BioPharma Inc.
  • [F5]Acquired in exchange for all of Alain Bankier's Class C warrants of Intiva BioPharma Inc.

Documents

1 file

Issuer

Intiva BioPharma Inc.

CIK 0001625288

→
Entity typeother

Related Parties

1
  • filerCIK 0001719591

Filing Metadata

Form type
4
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 1:25 PM ET
Size
11.7 KB
View on SEC.gov